688581 Hangzhou AGS Medtech
- 51.16
- +1.37+2.75%
Hangzhou AGS Medtech News
As of June 20, 2024, there were 5,289 shareholders in Anjiesi (688581.SH) company.
On June 21st, Gelunhui reported that as of June 20th, 2024, Angelcare's shareholders amounted to 5,289.
Should You Buy Hangzhou AGS MedTech Co., Ltd. (SHSE:688581) For Its Upcoming Dividend?
It looks like Hangzhou AGS MedTech Co., Ltd. (SHSE:688581) is about to go ex-dividend in the next 3 days. The ex-dividend date occurs one day before the record date which is the day on which sharehol
Anges (688581.SH) will distribute 10 shares for every 4 shares held in 2023, and the record date for the equity distribution is June 20th, with a dividend of 14.5 yuan.
Anji Technology (688581.SH) announced that the company will distribute annual equity dividends to all shareholders in 2023...
AnjieSi (688581. SH): has repurchased a cumulative total of 401,400 shares of the company's stock.
On June 3, Gelunhui reported that Anjesi (688581.SH) has announced that as of May 31, 2024, the company has repurchased a total of 401,400 shares of the company's stock through centralized bidding trading, accounting for 0.69% of the company's total share capital of 57,870,971 shares. The highest and lowest repurchase prices were 82.70 yuan/share and 72.95 yuan/share respectively, and the total amount paid was 30.9679 million yuan (excluding stamp duty, commission and other fees).
Angus (688581.SH): As of May 20, 2024, the number of shareholders in the company was 5,385
Gelonghui, May 21丨Anjess (688581.SH) said on an interactive platform that as of May 20, 2024, the number of shareholders of the company was 5,385.
Angus (688581.SH): As of May 10, 2024, the number of shareholders in the company was 5,168
Gelonghui, May 14 | Angel (688581.SH) said on an interactive platform that as of May 10, 2024, the number of shareholders of the company was 5,168.
About 15.3647 million restricted shares of Angus (688581.SH) will be listed and circulated on May 20
Angus (688581.SH) announced that the restricted shares listed and in circulation are limited to the company's initial public offering...
We Think That There Are Issues Underlying HangzhouS MedTech's (SHSE:688581) Earnings
Unsurprisingly, Hangzhou AGS MedTech Co., Ltd.'s (SHSE:688581) stock price was strong on the back of its healthy earnings report. However, we think that shareholders may be missing some concerning de
Hangzhou AGS MedTech Co., Ltd.'s (SHSE:688581) Most Bullish Insider Is CEO Cheng Zhang, and Their Holdings Value Went up by 13% Last Week
Key Insights Significant insider control over HangzhouS MedTech implies vested interests in company growth A total of 2 investors have a majority stake in the company with 55% ownership Instituti
Angus (688581.SH): As of April 19, 2024, the number of shareholders of the company was 5,154
Gelonghui, April 22丨Anjess (688581.SH) said on an interactive platform that as of April 19, 2024, the number of shareholders of the company was 5,154.
Angus (688581.SH): Net profit of 52.78 million yuan in the first quarter increased 54.22% year-on-year
Gelonghui, April 22丨Angus (688581.SH) released its first quarter report. Operating revenue was 110 million yuan, up 23.35% year on year, net profit was 52.78 million yuan, up 54.22% year on year, after deducting non-net profit of 48.27 million yuan, up 41.44% year on year, with basic earnings of 0.91 yuan per share.
Angus (688581.SH): As of April 10, 2024, the number of shareholders in the company was 5,104
Gelonghui, April 15 | Angel (688581.SH) said on the interactive platform that as of April 10, 2024, the number of shareholders of the company was 5,104.
Angus (688581.SH): A total of 264,400 shares have been repurchased
Gelonghui, April 1 | Angel (688581.SH) announced that as of March 31, 2024, the company had repurchased 264,400 shares of the company's shares through centralized bidding transactions, accounting for 0.45% of the company's total share capital of 57,870,971 shares. The highest price of the repurchase transaction was 82.70 yuan/share, the lowest price was 73.00 yuan/share, and the total amount of capital paid was 20.3615 million yuan (excluding fees such as stamp duty and transaction commissions).
Hangzhou AGS MedTech Co., Ltd.'s (SHSE:688581) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?
It is hard to get excited after looking at HangzhouS MedTech's (SHSE:688581) recent performance, when its stock has declined 33% over the past three months. But if you pay close attention, you might
Angus (688581.SH): As of March 20, 2024, the number of shareholders of the company was 5,536
Gelonghui, March 21丨Anjess (688581.SH) said on an interactive platform that as of March 20, 2024, the number of shareholders of the company was 5,536.
Angus (688581.SH): As of March 8, 2024, the number of shareholders in the company was 5,257
Gelonghui, March 11 | Angel (688581.SH) said on an interactive platform that as of March 8, 2024, the number of shareholders of the company was 5,257.
Angus (688581.SH): A total of 91,000 shares have been repurchased
Gleneagles (688581.SH) announced on March 4, 2024, that as of February 29, 2024, the company had repurchased 90,996 shares through centralized bidding transactions, accounting for 0.16% of the company's total share capital of 57,870,971 shares. The highest price of the repurchase transaction was 82.70 yuan/share, the lowest price was 77.40 yuan/share, and the total amount of capital paid was RMB 7,244,762.32 (excluding transaction fees such as stamp duty and transaction fees).
Hangzhou AGS MedTech Co., Ltd.'s (SHSE:688581) Low P/E No Reason For Excitement
Hangzhou AGS MedTech Co., Ltd.'s (SHSE:688581) price-to-earnings (or "P/E") ratio of 22.4x might make it look like a buy right now compared to the market in China, where around half of the companies h
Angel's (688581.SH) performance report: 2023 net profit of 217 million yuan increased 49.71% year-on-year
Gelonghui, Feb. 26 | Angel (688581.SH) announced the 2023 Annual Results Report. In 2023, the company achieved total operating revenue of 508.7485 million yuan, an increase of 37.09% over the same period of the previous year; net profit attributable to owners of the parent company was 216.974 million yuan, an increase of 49.71% over the same period of the previous year; net profit attributable to owners of the parent company after deducting non-recurring gains and losses was 21.7.972 million yuan, an increase of 48.27% over the same period of the previous year.
Angus (688581.SH): 17,000 shares repurchased for the first time
GLONGHUI, Feb. 22 | Angel (688581.SH) announced that on February 22, 2024, the company repurchased 16,996 shares for the first time through the Shanghai Stock Exchange trading system, accounting for 0.03% of the company's total share capital of 57,870,971 shares. The highest price of the repurchase transaction was 78.15 yuan/share, the lowest price was 77.40 yuan/share, and the total amount of capital paid was RMB 1,324,707 (excluding transaction fees such as stamp duty and transaction fees).
Analysis
Price Target
No Data
